Contact Us

Get 30% Free Customization on This Report

Published Date: April, 2019

Pulmonary Drugs Market (Drug Class - Long-acting Beta2-agonists (LABA), Short-acting Beta2-agonists (SABA), Anticholinergics, Inhaled Corticosteroids (ICS), Antihistamines, Vasodilators, and Other Drug Class; Application - Pulmonary Arterial Hypertension, Cystic Fibrosis, Asthma & COPD, and Other Applications; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Other Distribution Channel): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

Chapter Name Price
Chapter - 1: Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

Free
Chapter - 2: Executive Summary

2.1.   Pulmonary Drugs Market Highlights

2.2.   Pulmonary Drugs Market Projection

2.3.   Pulmonary Drugs Market Regional Highlights

250
Chapter - 3: Global Pulmonary Drugs Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3.   Porter's Five Forces Analysis

3.4.   IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Drug Class

3.4.2. IGR-Growth Matrix Analysis by Application

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5.   Value Chain Analysis of Pulmonary Drugs Market

500
Chapter - 4: Pulmonary Drugs Market Macro Indicator Analysis
250
Chapter - 5: Global Pulmonary Drugs Market by Drug Class

5.1.   Long-acting Beta2-agonists (SABA)

5.2.   Short-acting Beta2-agonists (SABA)

5.3.   Anticholinergics

5.4.   Inhaled Corticosteroids (ICS)

5.5.   Antihistamines

5.6.   Vasodilators

5.7.   Other Drug Class

750
Chapter - 6: Global Pulmonary Drugs Market by Application

6.1.   Pulmonary Arterial Hypertension

6.2.   Cystic Fibrosis

6.3.   Asthma & COPD

6.4.   Other Applications

750
Chapter - 7: Global Pulmonary Drugs Market by Distribution Channel

7.1.   Hospital Pharmacies

7.2.   Retail Pharmacies

7.3.   Drug Stores

7.4.   Other Distribution Channel

750
Chapter - 8: Global Pulmonary Drugs Market by Region 2019-2025

8.1.   North America

8.1.1. North America Pulmonary Drugs Market by Drug Class

8.1.2. North America Pulmonary Drugs Market by Application

8.1.3. North America Pulmonary Drugs Market by Distribution Channel

8.1.4. North America Pulmonary Drugs Market by Country

8.2.   Europe

8.2.1. Europe Pulmonary Drugs Market by Drug Class

8.2.2. Europe Pulmonary Drugs Market by Application

8.2.3. Europe Pulmonary Drugs Market by Distribution Channel

8.2.4. Europe Pulmonary Drugs Market by Country

8.3.   Asia-Pacific

8.3.1. Asia-Pacific Pulmonary Drugs Market by Drug Class

8.3.2. Asia-Pacific Pulmonary Drugs Market by Application

8.3.3. Asia-Pacific Pulmonary Drugs Market by Distribution Channel

8.3.4. Asia-Pacific Pulmonary Drugs Market by Country

8.4.   RoW

8.4.1. RoW Pulmonary Drugs Market by Drug Class

8.4.2. RoW Pulmonary Drugs Market by Application

8.4.3. RoW Pulmonary Drugs Market by Distribution Channel

8.4.4. RoW Pulmonary Drugs Market by Sub-region

2000
Chapter - 9: Company Profiles and Competitive Landscape

9.1.   Competitive Landscape in the Global Pulmonary Drugs Market

9.2.   Companies Profiles

9.2.1. Sunovion Pharmaceuticals Inc.

9.2.2. AstraZeneca

9.2.3. Novartis AG

9.2.4.  F. Hoffmann-La Roche Ltd

9.2.5.  GlaxoSmithKline Plc.

9.2.6.  Teva Pharmaceutical Industries Ltd.

9.2.7.  Merck Sharp & Dohme Corp

9.2.8. Boehringer Ingelheim International GmbH.

9.2.9. Actelion Pharmaceuticals Ltd

9.2.10.   Others

1500
Chapter - 10: Appendix

10.1.   Primary Research Findings and Questionnaire

*included in report
The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

sign up for our newsletter